Evidence map›Paper›PMID 40270816›Full record

ArticleFrontiers in microbiology2025

Resolution of MALDI-TOF compared to whole genome sequencing for identification of

Farnaz Mazhari, Aaron B Regberg, Christian L Castro, Michael G LaMontagne

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. MicrobioME: a CURE model for diverse microbiology laboratory classrooms.Journal of microbiology & biology education · 2026
    Article
  2. Article
  3. Article
  4. Deep space environment empowering drug design and development.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Farnaz MazhariDepartment of Biology and Biotechnology, University of Houston-Clear Lake, Houston, TX, United States.
Aaron B RegbergAstromaterials Research and Exploration Science (ARES) Division, NASA Johnson Space Center, Houston, TX, United States.
Christian L CastroJES Tech, NASA Johnson Space Center, Houston, TX, United States.
Michael G LaMontagneDepartment of Biology and Biotechnology, University of Houston-Clear Lake, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bacteria are frequently isolated from surfaces in cleanrooms, where astromaterials are curated, at NASA's Lyndon B. Johnson Space Center (JSC). Methods: To address this, we selected 15 isolates for analysis with WGS and MALDI-TOF MS. Hybrid next-generation (Illumina) and 3rd-generation (nanopore) sequencing were used to draft genomes. Mass spectra, generated with MALDI-TOF MS, were processed with custom scripts to identify clusters of closely related isolates. Results: MALDI-TOF MS and WGS identified 13/15 and 9/14 at the species level, respectively, and clusters of species generated from MALDI-TOF MS showed good agreement, in terms of congruence of partitioning, with phylotypes generated with WGS. Pairs of strains that were > 94% similar to each other, in terms of average amino acid identity (AAI) predicted by WGS, consistently showed cosine similarities of mass spectra >0.8. The only discordance was for a pair of isolates that were classified as Discussion: Since MALDI-TOF MS costs less than whole genome sequencing and offers a throughput of hundreds of isolates per hour, this approach appears to offer a cost-efficient option for identifying

Indexed as

astromaterialsBacillusbuiltcleanroomMALDI-TOFNASAwhole genome sequencing

Identifiers

PMID40270816
PMCPMC12017291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.